Iterum Therapeutics plc (ITRM) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Earnings Reports

• Iterum Therapeutics (ITRM) Q3 2025: Orlimba Coverage Hits 16% of Insured Lives, Commercial Reach Expands
  November 14, 2025
• Iterum Therapeutics (ITRM) Q2 2025: Orlinva Launch Targets 2,300 Prescribers in Seven-State Rollout
  August 05, 2025
• Iterum Therapeutics (ITRM) Q2 2025: G&A Expense Surges 121% as Orlinva Launch Nears
  August 05, 2025

Browse all companies